|Articles|August 1, 2019 (Updated: November 15, 2020)

Pharmaceutical Executive

  • Pharmaceutical Executive-08-01-2019
  • Volume 39
  • Issue 8

Pharmaceutical Executive, August 2019 Issue (PDF)

Click the title above to open the Pharmaceutical Executive August 2019 issue in an interactive PDF format.
External Link - Pharm Exec_August 2019.pdf

Articles in this issue

over 6 years ago

A Look Back & Forward on Innovation

over 6 years ago

Routes to Exclusivity in Cell-Based Therapy Development

over 6 years ago

Gene Therapy: Managing the Clinical Trial Minefields

over 6 years ago

The Call to Cure: Geoff MacKay, AVROBIO

over 6 years ago

Four Takeaways from the Zolgensma Pricing Storm

over 6 years ago

FDA Faces ‘Explosion’ in Growth of Gene Therapies

over 6 years ago

Mapping Out the Future of Cell and Gene Therapy

over 6 years ago

High-Stakes Manufacturing: Mitigating the Risks

over 6 years ago

Gene Therapy: How ‘Advanced’ is Europe?

over 6 years ago

Luxturna: A Vision for Curative Therapy Access

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content